Using US health system data from an observational cohort study, HCV is under-documented on death certificates. Only 19% of those with known HCV infection had HCV listed on their death certificate although two-thirds had pre-mortem indications of chronic liver disease. 
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Background:
Chronic hepatitis C virus (HCV) infection is estimated to infect 2.7-3.9 million persons in the United States. 1 Recent research indicates that the reported numbers of deaths recorded with HCV on the death certificate have been increasing and now supersede HIV infection as a cause of death. 2, 3 Of deaths from 1999-2007 with HCV infection listed as a primary or underlying cause of death, 57% had chronic liver disease as a cause 2 but many also had extra-hepatic manifestations. 4 Presence of HCV may potentially accelerate the disease process in heart disease, [5] [6] [7] diabetes, 8, 9 various malignancies, 10, 11 and genitourinary conditions. 12, 13 In this study, we looked at hepatic and extra-hepatic causes of death for a cohort of hepatitis Cinfected patients in care in the United States. We used data from a large ongoing cohort study of over 11,000 HCV patients at four US health systems. Our goal was to analyze rates and causes of death for those with known pre-mortem HCV infection and compare these to national death data.
Methods:
Algorithms for inclusion in the Chronic Hepatitis Cohort Study (CHeCS) were developed and applied to the electronic health record with the goal of capturing the greatest number of verifiable chronic hepatitis C cases. Criteria for inclusion and composition of the CHeCS cohort have been summarized in a previous report. 14 Briefly, the initial cohort was created based on analysis of electronic health records Each health system compared cohort patient records to the National Death Index (NDI), Social Security Death Index (SSDI), or electronic state death registries to enhance death ascertainment through 2010; the KPNW site was able to compare records through 2009. All three systems are central databases that provide similar information, although from different sources. The SSDI obtains information from the Social Security Administration whereas the NDI confirms mortality through a standardized process from state vital statistics offices. 15 The KPNW site matched data with the electronic state death registry and HFHS and GHS matched their data to the SSDI. The KPHI site matched their data against the NDI. All sites downloaded causes of death available in those data sources for the matches that were identified; the downloaded information was believed to be a complete list of all causes contained on the death certificate. Cause of death information was not available for patients who were known to be deceased via information obtained from the electronic health record or through survey contact attempts but without a match in the utilized death indices. The proportion of deaths with missing data was analyzed by site.
As patients were selected for cohort eligibility based on health service encounters from 2006- For the comparative analysis of CHeCS rates with MCOD rates, we standardized CHeCS allcause and disease-specific death rates to the age distribution of the U.S. Census population in 2008, since it was the median year of our study period. For the calculation of MCOD rates, using the same time period, age criteria, and ICD-10 groupings, we classified a death as belonging to that group if the associated ICD-10 codes were listed as the underlying cause of death or one of the multiple causes of death in the record axis. MCOD mortality rates were calculated by dividing the average number of deaths for each category by the average number of persons in the U.S. Census population. The statistical difference between CHeCS and MCOD mortality rates was assessed using the Pearson Chi-Square test, and a p-value of less than 0.05 was considered statistically significant. To examine the likelihood of having a death with the group-specific category listed as a cause of death in the CHeCS cohort relative to the general U.S. population, we calculated the relative risk and 95% confidence intervals (CI) for each of the fifteen groups. Mean age for CHeCS and MCOD data was also calculated by cause of death with the statistical significance noted by each category.
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We analyzed the EHRs of cases to determine if they had ICD-9-CM diagnosis codes indicating chronic liver disease. Cases who had at least one ICD-9-CM code for liver transplantation, hepatocellular carcinoma, liver failure, hepatic encephalopathy, portal hypertension, esophageal varices, ascites, gastrointestinal hemorrhage, or other sequelae of chronic liver disease during a health service encounter from 2006-2010 were considered to have chronic liver disease.
In addition to ICD-9 codes, we examined liver biopsy rates and results in the CHeCS HCV patients. As most infected persons do not have a biopsy, we also analyzed pre-mortem FIB-4 scores, calculated from aspartate aminotransferase (AST), alanine aminotransferase (ALT), platelet count, and patient age, to validate our definition of chronic liver disease. 17, 18 These indices are a validated noninvasive serum-based biomarker of liver fibrosis, and a score of 2.0 or higher identifies 88% of those with at least moderate fibrosis or a higher stage of liver fibrosis. 19 For all deaths, we selected the FIB-4 score closest to death and if more than one score was present on the date closest to death, the mean FIB-4 score of that date was calculated.
Results:
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The age-adjusted CHeCS mortality rate in these HCV-infected patients was 12,854 per 100,000 persons compared to the MCOD mortality rate of 1,046 per 100,000 persons. The age-adjusted mortality rate for all liver disease categories in CHeCS was higher than the national MCOD rate; for example, alcohol-related liver disease was 6 times greater while other hepatitis was 86 times higher than the national rate ( Table 2 ). The most frequently cited cause of death was non-alcohol related liver disease; it was listed for 32% of all deaths (513 /1,590). The CHeCS mortality rate among persons with non-alcohol related liver disease was 669 vs. 51 per 100,000 for alcohol-related liver disease. In addition, all ageadjusted death rates from extra-hepatic causes were higher than the national MCOD rates; the highest rates were seen with genitourinary causes, mental/behavioral disorders, and diabetes ( Table 2 ). Of 1,590 deaths, only 12 (1%) were due to intentional self-harm, 93 (6%) due to sepsis due to any cause, and none were due to overdose/poisonings. The overall mean age of death was 59 for CHeCS cases and 74 years for MCOD cases and was statistically significantly lower for all disease categories (Table 4) . Those with non-hepatic causes of death in the CHeCS population had a mean age of death that was 11-19 years younger when compared to national data, with the exception of the few (40) patients with HIV-and HCV coinfection whose age was slightly lower (52 vs 48 yrs respectively) at time of death.
We conducted a review of the records from one site to confirm the accuracy of our results. We verified our cause of death data completeness against the original death certificate obtained from the EHR for all 84 patients from Henry Ford Health System who died of liver-related illness without HCV listed as a cause of death. Among these patients we found 99% (83/84) agreement between the EHR records and death certificates regarding cause of death information.
Discussion:
Data from this study suggests a much greater role of HCV on mortality in the United States than has been previously understood based on analyses of death certificate data. The data in this paper document and contradict prevalent views that, perhaps because of its long incubation period (30 years),
HCV infection is an indolent infection that is not of urgent concern. Originally intended as a study of causes of death in approximately 1,600 well-characterized decedent HCV patients in the CHeCS, we indicating pre-mortem liver disease--and 76% had FIB4 scores indicative of substantial or more liver damage-this suggests that total US deaths contributed to by HCV total at least 53,000.
Our results may be a conservative estimate as recent studies indicate that only about half of all HCV-infected persons have been diagnosed with the infection. [20] [21] [22] Further, approximately 50% of all deaths in those with known HCV had liver disease listed on their death certificates. Thus, even if we exclude other diseases associated with HCV infection such as diabetes and non-Hodgkin lymphoma, [23] [24] [25] [26] it appears that most are dying not just with HCV but in possibly from HCV. These considerations are especially important because identifying and treating HCV patients in an era of rapidly evolving and effective, curative therapies could have a major public health impact.
Often, the high mortality and burden from HCV infection are minimized because other non-HCVrelated causes of death are considered to be more proximal or immediate reasons. For example, in a recent survey of New York resident physicians, over-documentation of cardiopulmonary causes of death and other inaccuracies--both knowing and unavoidable--were reported; those surveyed believe that the current cause-of-death reporting system is generally inaccurate. 27 This study also indicates that in the HCV-infected population over 70% had pre-mortem liver disease by ICD-9-CM electronic hospital record coding, liver biopsy, or FIB-4 score. So, in addition to under-recording HCV infection, even verified pre-mortem liver disease is also under-recorded, Further, whether the death was considered HCV or non-A c c e p t e d M a n u s c r i p t cause mortality in the general population (74 years), a finding similar to previous research. 28 The mortality rate estimated from this analysis was twelve times higher than the general population; this is much higher than the two-to-five times higher mortality rates in HCV-infected vs uninfected persons seen in other studies. [29] [30] [31] [32] Even with significant underreporting, persons who died in our cohort with non-alcohol related liver disease had 24 times the risk of death and those with liver cancer had almost 29 times the risk of death compared to over 12 million deaths in the age-matched general population. This effect was seen with extra-hepatic causes as well: compared to the general population, cases had three times the rate of injuries and genitourinary causes of death, ten times the rate of HIV, and twice the rate of mental/behavioral disorders. Other researchers have attributed higher rates of injuries/trauma as well as mental/behavioral disorders to lifestyle factors, including a previous history of substance abuse. 7, 33 However, results from our death certificate data show that only 1% of CHeCS patients had suicide listed, 6% had sepsis, and none died of overdose or poisoning.
Our data represent findings from four health care systems in the United States and thus have a number of limitations. While two sites have transplant centers associated with them, we cannot measure how many patients are "attracted" to these medical centers because they have tertiary care facilities vs the fact that they are in the catchment area of these large integrated health systems. However, as only a minority (10%) of the CHECS decedents were seen at the transplant centers, these patients do not affect the overall picture. Level of care provided at a particular site should not affect the low rate of death certificate recordings of HCV (29%). Due to the variability in the definition of ICD-10 mortality codes used for chronic liver disease, we compared the codes that we used for our definition of chronic liver disease with a previously established definition. We found that for both definitions, 46% of cases were identified as having liver-related causes of death. 34 This concordance further substantiates our findings.
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An additional limitation is the use of the FIB-4 index as a measure of chronic liver disease; although validated, changes to liver enzymes and platelet count may be affected by non-liver related conditions such as infection or malignancy. However, the overlap between liver disease defined by ICD-9-CM codes and FIB-4 scores correlates with the findings using the ICD-10 mortality codes indicating that there is truly underlying liver disease in patients dying with and from HCV.
In summary, our analysis of a known HCV-infected cohort demonstrates that less than one-fifth of deaths in HCV-infected persons are coded as having HCV; this indicates a significant underestimation of the number of deaths among people with HCV and the true medical and public health impact of HCV.
In this analysis, we have tried to be clear about the difference between dying with HCV and dying from HCV, but both represent a substantial public health burden. For purposes of public health, policy planning, disease modeling, and medical care, this is a huge burden that should be reported and hopefully spur public health action as curative, all-oral therapies are becoming available to treat HCV. Addressing the true impact of HCV, including of those chronically infected with HCV who are not utilizing health services, will be essential to appropriately respond to this epidemic.
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